Key points are not available for this paper at this time.
Treatment with gliptins significantly increased the risk for acute pancreatitis in a combined analysis of three large controlled randomized trials.
Tkáč et al. (Thu,) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: